/People

Richard Heyman

InvestorFounder

Venture Partner at ARCH Venture Partners · Founder at Dewpoint Therapeutics · Chairman, Founder, Scientific Advisory Board at ORIC Pharmaceuticals · Founder at Aragon Pharmaceuticals

Encinitas, California

Writes $50K – $150M checks · typically $25M

FoundedAragon PharmaceuticalsArchitect TherapeuticsDewpoint TherapeuticsORIC Pharmaceuticals

Find your path to Richard

Sign up to see every warm intro you have to Richard

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Richard. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Likely email· guessed from name + firm domain, not firm-published

Founder at Dewpoint Therapeutics

Intro paths

→

In turn, Richard can intro founders to Dewpoint Therapeutics's investors below.

Co-founders at Dewpoint Therapeutics

AHAnthony Hyman, Ph.D.
Anthony Hyman, Ph.D.Director
THTony Hyman
Tony HymanScientific Co-founder
RY
Rick YoungScientific Co-founder

Chairman, Founder, Scientific Advisory Board at ORIC Pharmaceuticals

Intro paths

→

In turn, Richard can intro founders to ORIC Pharmaceuticals's investors below.

Co-founders at ORIC Pharmaceuticals

CSCharles Sawyers
Charles SawyersFounder, Scientific Advisory Board
SL
Scott LoweFounder, Scientific Advisory Board

Founder at Aragon Pharmaceuticals

Intro paths

→

In turn, Richard can intro founders to Aragon Pharmaceuticals's investors below.

Deals · 3

Enliven TherapeuticsBoard seat

via ARCH Venture Partners · filed Apr 2024 · $90M raise

Vividion TherapeuticsBoard seat

via ARCH Venture Partners · filed May 2019 · $82M raise

MetacrineBoard seat

via ARCH Venture Partners · filed Nov 2016 · $37.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

Pelage

Sources: SEC Form D filings · curated public sources.

Colleagues at ARCH Venture Partners

Frequently asked questions

Who is Richard Heyman?
Venture Partner at ARCH Venture Partners
Where does Richard Heyman work?
Richard Heyman is Founder of Aragon Pharmaceuticals and Venture Partner at ARCH Venture Partners and Co-founder at Dewpoint Therapeutics and Chairman, Founder, Scientific Advisory Board at ORIC Pharmaceuticals.
What check size does Richard Heyman write?
Richard Heyman typically writes checks of $50K – $150M.
What companies did Richard Heyman found?
Richard Heyman founded Aragon Pharmaceuticals, Architect Therapeutics, Dewpoint Therapeutics, ORIC Pharmaceuticals.
What boards does Richard Heyman sit on?
Richard Heyman holds tracked board seats at Enliven Therapeutics, Metacrine, Vividion Therapeutics.
What companies has Richard Heyman invested in?
Investments tracked here include Pelage.

Founder mafias

About this profile. Compiled from public sources — ARCH Venture Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights